Nicolaus Kröger, MD, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, briefly comments on the importance of bridging CAR-T therapy in relapsed/refractory (R/R) patients with mantle cell lymphoma (MCL) and follicular lymphoma (FL). This interview took place at the 7th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) in Berlin, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.